Box score
Cyclacel Pharmaceuticals, Inc.
Reported $8M sold in a new Form D filed May 17, 2024 (Berkeley Heights, New Jersey).
- Biggest raise
- $8M filed May 17, 2024
- League
- Bio & Health Biotechnology
- Based in
- Berkeley Heights, New Jersey
- Season rank
- #397 of 1,389 in the Bio & Health League; #2343 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 5
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-03-25 | New notice | $1M | $1M | SEC |
| 2025-02-14 | New notice not ranked | $0 | $25M | SEC |
| 2025-02-14 | New notice not ranked | $0 | — | SEC |
| 2024-11-26 | New notice | $2.1M | $2.1M | SEC |
| 2024-05-17 | New notice | $8M | $8M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1130166.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | ChemoMouthpiece, LLC rookie | Bio & Health | $10M |
| 2 | Claris Biotherapeutics, Inc. | Bio & Health | $10M |
| 3 | electroCore, Inc. | Bio & Health | $7.8M |
| 4 | Avertix Medical, Inc. | Bio & Health | $7.1M |
| 5 | Avertix Medical, Inc. | Bio & Health | $6.8M |
| 6 | Linus Biotechnology Inc. | Bio & Health | $6.1M |